A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer.
Kurian AW; Thompson RN; Gaw AF; Arai S; Ortiz R; Garber AM; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2007, vol. 25, issue 6, p 634, ISSN 15277755. ISBN 15277755.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef